Arcline Investment Management Acquires Polypeptide Therapeutic Solutions from Columbus Venture Partners

by Columbus Venture Partners

Arcline Investment Management, a growth-oriented private equity firm with $4.3 billion of cumulative capital commitments, today announced the acquisition of Polypeptide Therapeutic Solutions, S.L. fr...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Columbus Venture Partners closes its lar...

by Columbus Venture Partners

This new fund is, in addition to being the most ambitious biotech inve...

Photos Stream